Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 26, 2015
Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6DTakeru Shiroiwa, Takashi Fukuda, Shunya Ikeda, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in JapanTakeru Shiroiwa, Shunya Ikeda, Shinichi Noto, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 17, 2020
Response Shift-Adjusted Treatment Effect on Health-Related Quality of Life in a Randomized Controlled Trial of Taxane Versus S-1 for Metastatic Breast Cancer: Structural Equation ModelingTatsunori Murata, Yoshimi Suzukamo, Takeru Shiroiwa, et al.Value in Health Regional Issues|January 9, 2024
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in JapanTomomi Maeda, Kensuke Moriwaki, Kosuke Morimoto, et al.Japanese Journal of Clinical Oncology|May 11, 2006
Evidence-based risk factors for seroma formation in breast surgeryKatsumasa Kuroi, Kojiro Shimozuma, Tetsuya Taguchi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 30, 2004
[Reliability and validity of the functional assessment of chronic illness therapy-spiritual (FACIT-Sp) Japanese version in cancer patients--a preliminary study]Wataru Noguchi, Tatsuya Ohno, Satoshi Morita, et al.Nippon Ganka Gakkai Zasshi|April 28, 2007
[Assessment of the quality of life in patients with age-related macular degeneration 1 year after photodynamic therapy]Tetsuhiro Kyo, Mitsuko Yuzawa, Kasumi Tochigi, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Comparison of EQ-5D scores among anthracycline-containing regimens followed by taxane and taxane-only regimens for node-positive breast cancer patients after surgery: the N-SAS BC 02 trialTakeru Shiroiwa, Takashi Fukuda, Kojiro Shimozuma, et al.Breast Cancer Research and Treatment|January 12, 2012
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04)Hiroyuki Takei, Shozo Ohsumi, Kojiro Shimozuma, et al.Breast Cancer (Tokyo, Japan)|November 16, 2005
Pathophysiology of seroma in breast cancerKatsumasa Kuroi, Kojiro Shimozuma, Tetsuya Taguchi, et al.Pageof 9